US Edition
Reduction in Onchocerca volvulus infection prevalence and intensity in Logo Health Zone in Ituri, Democratic Republic of the Congo, in the absence of interventions: Results of screening for clinical trials of moxidectin vs. ivermectin in 2010 and 2021-202
Summary by researchsquare.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Reduction in Onchocerca volvulus infection prevalence and intensity in Logo Health Zone in Ituri, Democratic Republic of the Congo, in the absence of interventions: Results of screening for clinical trials of moxidectin vs. ivermectin in 2010 and 2021-202
Background: In Ituri province, 7576 and 1056 volunteers living in the Health Zone (ZdS) Logo and Nyarambe, respectively, were screened in 2021-2023 for two studies comparing efficacy and/or safety of moxidectin and ivermectin in individuals with or without detectable Oncho...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
